Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
The MAPS Medical Affairs Textbook
Medical Affairs is one of the three strategic pillars of the pharmaceutical and MedTech industries, but while clear career paths exist for Commercial and Research & Development, there is no formal training structure for Medical Affairs professionals. Medical and scientific expertise is a prerequisite for entry into the function, and many people transitioning into Medical Affairs have advanced degrees such as PhD, MD, or PharmD. However, these clinical/scientific experts may not be especially well-versed in aspects of industry such as the drug development lifecycle, crossfunctional collaborations within industry, and digital tools that are transforming the ways Medical Affairs generates and disseminates knowledge. The MAPS Medical Affairs Textbook is both a primer for aspiring and early-career Medical Affairs professionals as well as a broad overview of Medical Affairs for those seeking to power a crossfunctional Medical Affairs career. This first-of-its-kind resource equips readers with the baseline skills and understanding to excel across Medical Affairs roles.
Features:
- Defines the purpose and value of Medical Affairs and provides clear career paths for scientific experts seeking their place within the pharmaceutical and MedTech industries.
- Provides guideance and baseline competencies for roles within Medical Affairs including Medical Communications, Evidence Generation, Field Medical, Compliance, and many others.
- Specifies the “true north” of the Medical Affairs profession as ensuring patients receive maximum benefit from industry innovations including drugs, diagnostics and devices.
- Presents the purpose and specific roles of Medical Affairs roles across organization types including biotechs, small/medium/large pharma and device/diagnostic companies, taking into account adjustments in the practice of Medical Affairs to meet the needs of developing fields.
- Leverages the expertise of over 80 Medical Affairs leaders across companies, representing the first unified, global understanding of the Medical Affairs profession.
Contributors
(Affiliations at time of publication)
Mónica de Abadal, SVP, Head of Medical Affairs, North America, Ipsen
Bill Altonaga, VP, Global Medical Safety and Governance, Becton Dickinson
Jim Alexander, CEO and Founder, Industry Pharmacists Organization
Rachele Berria, VP and Head of Medical, US Biopharmaceuticals, AstraZeneca
Idal Beer, VP Medical and Scientific Affairs, Medication Management Solutions, Becton Dickinson
George Betts, ED, Head of Medical Affairs Operations, Regeneron
Loubna Bouarfa, CEO and Founder, OKRA.ai
Isabelle Bocher-Pianka, Chief Patient Affairs Officer, Ipsen
Sokhon Bouy, Head of Area Medical Operations, Abbvie
Deb Braccia, Head of Global Medical Affairs Excellence, Kyowa Kirin
Kimberly Braithwaite, National Manager Medical Science Liaison, EMD Serono Canada
Søren Buur, Director, Head of Medical Affairs Operations, Lundbeck
Greg Christopherson, VP, Medical Affairs, Medline Industries
Sarah Clark, Head of Medical Affairs, Biogen Digital Health
Gail Cawkwell, Chief Medical Affairs Officer, Aclaris Therapeutics
Omar Dabbous, VP, Global Health Economics and Outcomes Research and Real World Evidence, AveXis
Joao Dias, Scientific Affairs Head, Haemonetics
Shontelle Dodson, EVP, Global Medical Affairs, Astellas
Maureen Doyle-Scharff, ED, Global Medical Grants, Pfizer
Victoria Elegant, VP, Medical, Asia Pacific and Global Lead, Access to Healthcare, Amgen
Ann Ford, Partner, Managing Director, HPS Advise
Wendy Fraser, ED, Field Medical Center of Excellence and Global Scientific Training, Merck
Monique Furlan, Global Field Based Medical Stakeholders Scientific Engagement Lead, Sanofi
Stacey Fung, Head, Global Medical Information, Gilead Sciences
Catrinel Galateanu, Head of Global Medical Affairs, UCB
Kathy Gann, Medical Affairs, MSL Professional
Arnaud Gatignol, Medical Operations Manager, bioMérieux
Suzanne Giordano, Head of Field Medical, Axsome Therapeutics
Suzana Giffin, VP, Global Medical and Scientific Affairs, Merck
Kristin Goettner, Sr. Director, Medical Information and Knowledge Integration, Janssen Scientific Affairs
Rebecca Goldstein, Senior Principal, Strategic Consulting, Envision
Oleks Gorbenko, Global Patient Affairs Director, Ipsen
Tricia Gooljarsingh, VP, Medical Affairs, Fulcrum Therapeutics
Andrew Greenspan, Chief Global Medical Affairs Officer, Janssen Pharmaceutical Companies, Johnson & Johnson
Ann Hartry, Associate VP, Value, Evidence and Outcomes, Neuroscience, Eli Lilly
Kristine Healey, Associate VP, COO, Medical Affairs Launch Readines, Eli Lilly
Meg Heim, President and Founder, Heim Global Consulting
Evelyn Hermes-DeSantis, Director, Research and Publications, phactMI; Professor Emerita, Rutgers, The State University of New Jersey
Klaus Hoerauf, VP, Global Medical and Scientific Affairs, Medication Delivery Solutions, Becton Dickinson
Noreen Hussain, Senior Medical Writer, MedComms Experts
Sandrine Jabouin, Account Director, MedComms Experts
Greta James-Chatgilaou, Director, Field Medical Strategy and Execution, Biogen Intercontinental Region
Renu Juneja, Head, Scientific Evidence and Communications, Oncology US Medical Affairs, Janssen
Tobi Karchmer, Chief Medical Officer, Baxter
Christopher Keenan, ED, External Engagement and Enablement, Global Medical, Bristol Myers Squibb
Richard Kemper, Global Medical Omnichannel Head, General Medicines, Sanofi
Dee Khuntia, Chief Medical Officer, Varian, A Siemens Healthineers Company
Karen King, EVP Scientific and Medical Services, Medical Communications, Open Health Scientific Communications
Joe Kohles, Senior Medical Strategy Consultant
Tamas Koncz, Medical Affairs Executive, NY
Charlotte Kremer, Medical Affairs Executive, Chief Medical Officer, MAPS
Bagrat Lalayan, ED, Global Medical Head, Women’s Cancer Care, Oncology, Eisai
Sean Lilienfeld, VP, Global Medical Affairs, Boston Scientific
Maureen Lloyd, Executive Director, LLOYDMJMC LLC
Deborah Long, SVP of Medical Affairs, Vertex Pharmaceuticals
David Macarios, VP, Global Health Economics and Outcomes Research and Real-World Evidence, Becton Dickinson
Robert Matheis, President and CEO, International Society for Medical Publication Professionals
Danny McBryan, Medical Affairs Executive
Siobhan Mitchell, Global Medical Office Head and Chief of Staff to SVP Medical Head, Sanofi
Mark Miller, Chief Medical Officer, bioMérieux
Hany Moselhi, SVP, Chief Medical Officer, Roche Diagnostics
Lori Mouser, Senior Director, Global Head of Scientific Engagement, Oncology Medical Affairs, Daiichi Sankyo
Ameet Nathwani, CEO, Dewpoint Therapeutics
Judith Nelissen, VP, Head Global Health Economics and Outcomes Research, Astellas
Liviu Niculescu, Chief Medical Affairs Officer, Innovative Medicines U.S., Novartis
Nikolai Nikolov, Medical Affairs Executive
Marie-Ange Noue, Sr. Director and Head of North America Scientific Communications, EMD Serono
Tam Nguyen, Deputy Director of Research, St. Vincent’s Hospital, Melbourne
Bjorn Oddens, SVP, Head of Global Medical and Scientific Affairs, Merck
Rishi Ohri, Head of Digital Excellence, Medical Affairs, Astellas
Kirtida Pandya, ED and Head, Medical Services and Operations, Sandoz
Jovanka Paunovich, Director, Strategic Portfolio Initiatives, US Medical Affairs, Oncology, Abbvie
Danie du Plessis, EVP, Medical Affairs, Kyowa Kirin
Peter Piliero, VP, Medical Affairs, Melinta Therapeutics
John Pracyk, Chief Medical Safety Officer, SVP, Medical and Scientific Affairs, Olympus
Charlotte Raabe-Hielscher, HRBP Lead, Established Markets Commercial, Astellas
Patrick Reilly, President, Reilly Consulting
Ross “Rusty” Segan, Chief Medical Officer (former), Medical and Scientific Affairs, Olympus
Jessica Santos, Global Compliance and Quality Director, DPO, Oracle Life Sciences
Holly Schachner, SVP of Clinical Development, Northsea Therapeutics
Roz Schneider, Head of Global Patient Affairs, BioMarin
Roslyn Schneider, VP, Head of Global Patient Affairs, BioMarin
Kirk Shepard, (former) CMO and SVP, Head of Global Medical Affairs, Oncology, Eisai
Sandra Silvestri, EVP and CMO, Ipsen Ronald Silverman, SVP, Chief Medical
Officer, 3M HealthCare
William Sigmund, EVP and Chief Medical Officer, Becton Dickinson
Darryl Sleep, SVP, Global Medical and Chief Medical Officer, Amgen
Garth Sundem, Director, Communications and Marketing, MAPS
Rich Swank, (former) Head of Field Medical, Amgen
Paul Tebbey, COO, Elusys Therapeutics
Ajay Tiku, Regional Medical Head, Innovative Medicines, Asia Pacific, Middle East and Africa (APMA), Novartis
Leonard Valentino, CEO, National Hemophilia Foundation
Marleen van der Voort, ED, Scientific Communications and Content, Astellas
Jill Voss, Head of Scientific Communications and Medical Information, Neuroscience Franchise, Novartis
Anna Walz, Founder, MedEvoke, CEO, Blue Highland Consulting
Stephanie Wei, Scientific Director and Team Lead, Alligent Group
Robin Winter-Sperry, President, Global Medical Affairs, Scientific Resilience Consulting
